These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 9665817

  • 1. Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair.
    Madlener M, Parks WC, Werner S.
    Exp Cell Res; 1998 Jul 10; 242(1):201-10. PubMed ID: 9665817
    [Abstract] [Full Text] [Related]

  • 2. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas.
    Kossakowska AE, Urbanski SJ, Watson A, Hayden LJ, Edwards DR.
    Oncol Res; 1993 Jul 10; 5(1):19-28. PubMed ID: 8369572
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of tissue inhibitor of metalloproteinases-3 in intestinal and cutaneous lesions of graft-versus-host disease.
    Salmela MT, Karjalainen-Lindsberg ML, Jeskanen L, Saarialho-Kere U.
    Mod Pathol; 2003 Feb 10; 16(2):108-14. PubMed ID: 12591962
    [Abstract] [Full Text] [Related]

  • 4. Differential regulation of fibulin, tenascin-C, and nidogen expression during wound healing of normal and glucocorticoid-treated mice.
    Fässler R, Sasaki T, Timpl R, Chu ML, Werner S.
    Exp Cell Res; 1996 Jan 10; 222(1):111-6. PubMed ID: 8549652
    [Abstract] [Full Text] [Related]

  • 5. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis.
    Tanney DC, Feng L, Pollock AS, Lovett DH.
    Dev Dyn; 1998 Sep 10; 213(1):121-9. PubMed ID: 9733107
    [Abstract] [Full Text] [Related]

  • 6. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K, Shigemasa K, Nagai N, Ohama K.
    Int J Oncol; 2000 Oct 10; 17(4):673-81. PubMed ID: 10995877
    [Abstract] [Full Text] [Related]

  • 7. Expression pattern of metalloproteinases and tissue inhibitors of matrix-metalloproteinases in cycling human endometrium.
    Goffin F, Munaut C, Frankenne F, Perrier D'Hauterive S, Béliard A, Fridman V, Nervo P, Colige A, Foidart JM.
    Biol Reprod; 2003 Sep 10; 69(3):976-84. PubMed ID: 12773401
    [Abstract] [Full Text] [Related]

  • 8. Expression of MMPs and TIMPs in human pterygia and cultured pterygium epithelial cells.
    Di Girolamo N, McCluskey P, Lloyd A, Coroneo MT, Wakefield D.
    Invest Ophthalmol Vis Sci; 2000 Mar 10; 41(3):671-9. PubMed ID: 10711680
    [Abstract] [Full Text] [Related]

  • 9. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes.
    Steen B, Sejersen S, Berglin L, Seregard S, Kvanta A.
    Invest Ophthalmol Vis Sci; 1998 Oct 10; 39(11):2194-200. PubMed ID: 9761302
    [Abstract] [Full Text] [Related]

  • 10. Human ageing impairs injury-induced in vivo expression of tissue inhibitor of matrix metalloproteinases (TIMP)-1 and -2 proteins and mRNA.
    Ashcroft GS, Herrick SE, Tarnuzzer RW, Horan MA, Schultz GS, Ferguson MW.
    J Pathol; 1997 Oct 10; 183(2):169-76. PubMed ID: 9390029
    [Abstract] [Full Text] [Related]

  • 11. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation.
    Teesalu T, Masson R, Basset P, Blasi F, Talarico D.
    Dev Dyn; 1999 Mar 10; 214(3):248-58. PubMed ID: 10090151
    [Abstract] [Full Text] [Related]

  • 12. The balance between proteinases and inhibitors in a murine model of proliferative retinopathy.
    Majka S, McGuire P, Colombo S, Das A.
    Invest Ophthalmol Vis Sci; 2001 Jan 10; 42(1):210-5. PubMed ID: 11133870
    [Abstract] [Full Text] [Related]

  • 13. Expression and localization of matrix metalloproteinases (MT1-MMP, MMP-2) and tissue inhibitor of metalloproteinase-2 (TIMP-2) during synepitheliochorial placentation of goats (Capra hircus).
    Uekita T, Yamanouchi K, Sato H, Tojo H, Seiki M, Tachi C.
    Placenta; 2004 Nov 10; 25(10):810-9. PubMed ID: 15451196
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Matrix metalloproteinase-9 expression and release from skin fibroblasts interacting with keratinocytes: Upregulation in response to sulphur mustard.
    Ries C, Popp T, Egea V, Kehe K, Jochum M.
    Toxicology; 2009 Sep 01; 263(1):26-31. PubMed ID: 18809459
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing.
    Kane CJ, Hebda PA, Mansbridge JN, Hanawalt PC.
    J Cell Physiol; 1991 Jul 01; 148(1):157-73. PubMed ID: 1907288
    [Abstract] [Full Text] [Related]

  • 20. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
    Hofmann UB, Westphal JR, Zendman AJ, Becker JC, Ruiter DJ, van Muijen GN.
    J Pathol; 2000 Jul 01; 191(3):245-56. PubMed ID: 10878545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.